Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:18 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1489–1512 of 21,040 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: Pain, Postoperative, Pain, Anxiety Postoperative
Interventions: VR-Biofeedback, VR-Distraction, 360 Video; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 8 Years to 18 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Solid Tumor, Adult, Healthy Donors, COVID-19 Donors
Interventions: Not listed
Lead sponsor: BioCytics, Inc.; Industry
Eligibility: 5 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2030
U.S. locations: 1
States / cities: Huntersville, North Carolina

Conditions: Persistence of Varicella Immunity
Interventions: Varicella vaccine; Biological
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Arthritis
Interventions: Live Music Therapy, Recorded Music Therapy, Control; Other
Lead sponsor: April Armstrong; Other
Eligibility: 18 Years and older
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Bladder Cancer
Interventions: Tremelimumab, Durvalumab, Bladder radiation, Intravesicular Therapy; Drug · Radiation
Lead sponsor: Daniel George, MD; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Lactating Mother
Interventions: Vyleesi (Bremelanotide Injection); Drug
Lead sponsor: Cosette Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Doral, Florida

Conditions: PreDiabetes, Obesity, Metabolic Disease, Body Weight Changes, Diabetes Mellitus
Interventions: Promotora-led Intervention (PLI), Usual care (UC); Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Breast Cancer
Interventions: Everolimus, Exemestane, Tamoxifen, Fulvestrant, Anastrozole, Letrozole, Toremifine; Drug
Lead sponsor: SCRI Development Innovations, LLC; Other
Eligibility: 18 Years and older · Female only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 8
States / cities: Fort Myers, Florida • Hollywood, Florida • Pensacola, Florida + 5 more

Conditions: Impaired Fasting Glucose, Impaired Glucose Tolerance, Vitamin D Insufficiency
Interventions: Placebo, 50K vitamin D2; Drug
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 35 Years to 85 Years · Male only
Enrollment: 205 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma, High Grade Glioma
Interventions: Dendritic Cell Vaccine, Tumor Lysate, Imiquimod, Leukapheresis; Biological · Drug · Procedure
Lead sponsor: Macarena De La Fuente, MD; Other
Eligibility: 13 Years to 99 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2022
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Obesity
Interventions: Galantamine, Placebo Oral Capsule, Intralipid, Heparin; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: HIV Disease, Depression, Affect, Psychological Stress
Interventions: Intervention; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Head and Neck Cancer
Interventions: Placebo, Ketamine Topical; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 99 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Glabellar Rhytides, Frown Lines Between the Eyebrows
Interventions: Mentor Purified Toxin Botulinum Toxin Type A, Preservative-free Saline; Drug
Lead sponsor: Mentor Worldwide, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 699 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Santa Barbara, California

Conditions: Pneumococcal Immunization
Interventions: Pneumococcal Conjugate Vaccine - formulation 1-SP0202-IIb, Pneumococcal Conjugate Vaccine - formulation 2-SP0202-VI, Pneumococcal Conjugate Vaccine - formulation 3-SP0202-VII, Pneumococcal 13 - valent conjugate vaccine-Prevnar 13, Pneumococcal Vaccine Polyvalent-Pneumovax 23; Biological
Lead sponsor: Sanofi; Industry
Eligibility: 50 Years to 84 Years
Enrollment: 750 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 17
States / cities: Anaheim, California • Rolling Hills Estates, California • Wheat Ridge, Colorado + 14 more

Conditions: Insomnia, Alcohol Use Disorder
Interventions: Cognitive Behavioral Therapy for Insomnia, Sleep Hygiene, Alcohol Use Disorder Treatment as Usual; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Alzheimer's Disease
Interventions: Not listed
Lead sponsor: Orasi Medical, Inc.; Industry
Eligibility: 50 Years to 90 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Chicago, Illinois • Elk Grove Village, Illinois

Conditions: Suicide
Interventions: Supporting Wellbeing with Everyday Experiences of Peers (SWEEP); Behavioral
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 14 Years to 18 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Asthma
Interventions: FLOVENT™ DISKUS™ 100 mcg BID, ADVAIR™ DISKUS™ 100/50 mcg BID; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 4 Years to 11 Years
Enrollment: 339 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 38
States / cities: Tucson, Arizona • Bakersfield, California • Fresno, California + 33 more

Conditions: Opioid Use Disorder, Cannabis Use
Interventions: Cannabis, Placebo Cannabis, Intranasal Opioid Agonist, Oral Opioid Agonist; Drug
Lead sponsor: Shanna Babalonis, PhD; Other
Eligibility: 18 Years to 55 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Heart Failure
Interventions: Left ventricular coronary sinus (BiV) configuration, Conduction system pacing-only configuration, Conduction System Pacing Optimized Therapy (CSPOT) configuration; Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 7
States / cities: Tampa, Florida • Chicago, Illinois • Houma, Louisiana + 4 more

Conditions: Acute Myeloid Leukemia
Interventions: Sertraline, Cytosine arabinoside, allogeneic stem cell transplantation; Drug · Procedure
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 2
States / cities: Baltimore, Maryland • New York, New York

Conditions: Long COVID
Interventions: sodium pyruvate nasal spray; Drug
Lead sponsor: Cellular Sciences, inc.; Industry
Eligibility: 18 Years to 40 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Springfield, Missouri

Conditions: Diabetes Mellitus, Type 2, Depressive Symptoms, Depression
Interventions: Cognitive Behavioral Therapy, Exercise, Group Discussions - Ongoing Support; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older · Male only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Search by objective public record fields.

Virtual Reality and Pain

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine

The Effect of Music Therapy Intervention on Pain and Anxiety in Adult Patients Undergoing Total Shoulder Arthroplasty

TRIO Bladder: A Study of Durvalumab Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation in Muscle-Invasive Bladder Cancer

Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk

Promotora-Led Intervention for Metabolic and Mental Health

Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer

D Vitamin Intervention in VA

Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma

Racial Differences in Vagal Control of Glucose Homeostasis

Optimizing Resilience and Coping in HIV Via Internet Delivery

Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse

Safety and Efficacy Study of Repeat Treatment With PurTox® Botulinum Toxin Type A for Frown Lines Between the Eyebrows

Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.

CBT-I on Alcohol Treatment Outcomes Among Veterans

Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG)

A Pilot Evaluation of a Digital Peer Support Intervention for Suicidal Adolescents

Fall Epidemic Viral Pediatric Study

Cannabis Effects on Opioid Self-Administration

Conduction System Pacing Optimized Therapy

Sertraline and Cytosine Arabinoside in Adults With Relapsed and Refractory AML

Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion